315 related articles for article (PubMed ID: 33116510)
1. In vitro Characterization and Release Studies of Combined Nonionic Surfactant-Based Vesicles for the Prolonged Delivery of an Immunosuppressant Model Drug.
Rasul A; Imran Khan M; Ur Rehman M; Abbas G; Aslam N; Ahmad S; Abbas K; Akhtar Shah P; Iqbal M; Ahmed Al Subari AM; Shaheer T; Shah S
Int J Nanomedicine; 2020; 15():7937-7949. PubMed ID: 33116510
[TBL] [Abstract][Full Text] [Related]
2. Development and in vitro characterization of niosomal formulations of immunosuppressant model drug.
Rehman M; Rasul A; Waqas MK; Khan MI; Sher M
Pak J Pharm Sci; 2018 Nov; 31(6 (Supplementary):2623-2628. PubMed ID: 30587470
[TBL] [Abstract][Full Text] [Related]
3. Oral bioavailability studies of niosomal formulations of Cyclosporine A in albino rabbits.
Ur Rehman M; Rasul A; Khan MI; Rasool M; Abbas G; Masood F; Nazir I; Iqbal M; Islam N; Hameed M; Shah PA
Pak J Pharm Sci; 2021 Jan; 34(1(Supplementary)):313-319. PubMed ID: 34275856
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of optimized zolmitriptan niosomal emulgel.
Mohamed MI; Abdelbary AA; Kandil SM; Mahmoud TM
Drug Dev Ind Pharm; 2019 Jul; 45(7):1157-1167. PubMed ID: 30919700
[No Abstract] [Full Text] [Related]
5. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits.
Attia IA; El-Gizawy SA; Fouda MA; Donia AM
AAPS PharmSciTech; 2007 Dec; 8(4):E106. PubMed ID: 18181527
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
[TBL] [Abstract][Full Text] [Related]
7. Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits.
Jain N; Verma A; Jain N
Drug Deliv; 2020 Dec; 27(1):888-899. PubMed ID: 32551978
[TBL] [Abstract][Full Text] [Related]
8. Enhanced oral bioavailability of griseofulvin via niosomes.
Jadon PS; Gajbhiye V; Jadon RS; Gajbhiye KR; Ganesh N
AAPS PharmSciTech; 2009; 10(4):1186-92. PubMed ID: 19856107
[TBL] [Abstract][Full Text] [Related]
9. Enhanced ocular bioavailability of fluconazole from niosomal gels and microemulsions: formulation, optimization, and in vitro-in vivo evaluation.
Soliman OAE; Mohamed EA; Khatera NAA
Pharm Dev Technol; 2019 Jan; 24(1):48-62. PubMed ID: 29210317
[TBL] [Abstract][Full Text] [Related]
10. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
[TBL] [Abstract][Full Text] [Related]
11. Nonionic surfactant-based vesicular system for transdermal drug delivery.
Ghanbarzadeh S; Khorrami A; Arami S
Drug Deliv; 2015 Dec; 22(8):1071-1077. PubMed ID: 24400680
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
Guinedi AS; Mortada ND; Mansour S; Hathout RM
Int J Pharm; 2005 Dec; 306(1-2):71-82. PubMed ID: 16263229
[TBL] [Abstract][Full Text] [Related]
13. Design and development of cefdinir niosomes for oral delivery.
Bansal S; Aggarwal G; Chandel P; Harikumar SL
J Pharm Bioallied Sci; 2013 Oct; 5(4):318-25. PubMed ID: 24302841
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Surfactant Composition and Surface Charge of Niosomes on the Oral Absorption of Repaglinide as a BCS II Model Drug.
Yaghoobian M; Haeri A; Bolourchian N; Shahhosseni S; Dadashzadeh S
Int J Nanomedicine; 2020; 15():8767-8781. PubMed ID: 33204087
[TBL] [Abstract][Full Text] [Related]
15. Formulation Development and Evaluation of Novel Vesicular Carrier for Enhancement of Bioavailability of Poorly Soluble Drug.
Sharma S; Bhatt S; Saini V
Pharm Nanotechnol; 2021; 9(1):70-82. PubMed ID: 33231151
[TBL] [Abstract][Full Text] [Related]
16. Development of Niosomal Vesicles Loaded Mometasone Furoate Gel for Transdermal Delivery and its Evaluation.
Rane BR; Chavan PY; Kate NS; Jain AS
Recent Adv Drug Deliv Formul; 2023; 17(4):300-313. PubMed ID: 37974444
[TBL] [Abstract][Full Text] [Related]
17. Development of a biocompatible creatinine-based niosomal delivery system for enhanced oral bioavailability of clarithromycin.
Ullah S; Shah MR; Shoaib M; Imran M; Elhissi AM; Ahmad F; Ali I; Shah SW
Drug Deliv; 2016 Nov; 23(9):3480-3491. PubMed ID: 27247018
[TBL] [Abstract][Full Text] [Related]
18. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery.
Bayindir ZS; Yuksel N
J Pharm Sci; 2010 Apr; 99(4):2049-60. PubMed ID: 19780133
[TBL] [Abstract][Full Text] [Related]
19. Sugar-based novel niosomal nanocarrier system for enhanced oral bioavailability of levofloxacin.
Imran M; Shah MR; Ullah F; Ullah S; Elhissi AM; Nawaz W; Ahmad F; Sadiq A; Ali I
Drug Deliv; 2016 Nov; 23(9):3653-3664. PubMed ID: 27886514
[TBL] [Abstract][Full Text] [Related]
20. Sorbitan ester niosomes for topical delivery of rofecoxib.
Das MK; Palei NN
Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
